4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-25-049495
Co-Chief Executive Officer sold 21,490 shares at $3.46 ($74,454)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Klee Justin B. Co-Chief Executive Officer | 2025-03-31 | Sale | −21,490 | $3.46 | $74,454 | 3,355,276 | D |
| Open-market sales · 21,490 sh · avg $3.46 · $74,454 | |||||||
Loading xslF345X05/ownership.xml…